Article Versions Notes

Ravensbergen CJ, Polack M, Roelands J, Crobach S, Putter H, Gelderblom H, Tollenaar RAEM, Mesker WE. Combined Assessment of the Tumor–Stroma Ratio and Tumor Immune Cell Infiltrate for Immune Checkpoint Inhibitor Therapy Response Prediction in Colon Cancer. Cells. 2021; 10(11):2935. https://doi.org/10.3390/cells10112935

Ravensbergen, Cor J., Meaghan Polack, Jessica Roelands, Stijn Crobach, Hein Putter, Hans Gelderblom, Rob A. E. M. Tollenaar, and Wilma E. Mesker. 2021. "Combined Assessment of the Tumor–Stroma Ratio and Tumor Immune Cell Infiltrate for Immune Checkpoint Inhibitor Therapy Response Prediction in Colon Cancer" Cells 10, no. 11: 2935. https://doi.org/10.3390/cells10112935

Ravensbergen, C. J., Polack, M., Roelands, J., Crobach, S., Putter, H., Gelderblom, H., Tollenaar, R. A. E. M., & Mesker, W. E. (2021). Combined Assessment of the Tumor–Stroma Ratio and Tumor Immune Cell Infiltrate for Immune Checkpoint Inhibitor Therapy Response Prediction in Colon Cancer. Cells, 10(11), 2935. https://doi.org/10.3390/cells10112935